354 related articles for article (PubMed ID: 11212265)
1. Bax accelerates tumorigenesis in p53-deficient mice.
Knudson CM; Johnson GM; Lin Y; Korsmeyer SJ
Cancer Res; 2001 Jan; 61(2):659-65. PubMed ID: 11212265
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
Luke JJ; Van De Wetering CI; Knudson CM
Cell Death Differ; 2003 Jun; 10(6):740-8. PubMed ID: 12761582
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
[TBL] [Abstract][Full Text] [Related]
4. Bax suppresses tumorigenesis and stimulates apoptosis in vivo.
Yin C; Knudson CM; Korsmeyer SJ; Van Dyke T
Nature; 1997 Feb; 385(6617):637-40. PubMed ID: 9024662
[TBL] [Abstract][Full Text] [Related]
5. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage.
Shibata MA; Liu ML; Knudson MC; Shibata E; Yoshidome K; Bandey T; Korsmeyer SJ; Green JE
EMBO J; 1999 May; 18(10):2692-701. PubMed ID: 10329616
[TBL] [Abstract][Full Text] [Related]
6. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways.
Kim K; Lee CK; Sayers TJ; Muegge K; Durum SK
J Immunol; 1998 Jun; 160(12):5735-41. PubMed ID: 9637482
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2.
Lu L; Chaudhury P; Osmond DG
J Immunol; 1999 Feb; 162(4):1931-40. PubMed ID: 9973461
[TBL] [Abstract][Full Text] [Related]
8. p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation.
Schuler M; Maurer U; Goldstein JC; Breitenbücher F; Hoffarth S; Waterhouse NJ; Green DR
Cell Death Differ; 2003 Apr; 10(4):451-60. PubMed ID: 12719722
[TBL] [Abstract][Full Text] [Related]
9. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells.
Li M; Hu J; Heermeier K; Hennighausen L; Furth PA
Cell Growth Differ; 1996 Jan; 7(1):3-11. PubMed ID: 8788028
[TBL] [Abstract][Full Text] [Related]
10. Stimulatory effect of topical application of caffeine on UVB-induced apoptosis in the epidermis of p53 and Bax knockout mice.
Lu YP; Lou YR; Peng QY; Xie JG; Conney AH
Cancer Res; 2004 Jul; 64(14):5020-7. PubMed ID: 15256477
[TBL] [Abstract][Full Text] [Related]
11. T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53.
Brady HJ; Salomons GS; Bobeldijk RC; Berns AJ
EMBO J; 1996 Mar; 15(6):1221-30. PubMed ID: 8635454
[TBL] [Abstract][Full Text] [Related]
12. p53, Bax and Bcl-2 in vivo expression in the murine thymus after apoptogenic treatments.
Denis G; Humblet C; Verlaet M; Boniver J; Defresne MP
Anticancer Res; 1998; 18(5A):3315-21. PubMed ID: 9858902
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cell death by lens-specific overexpression of bcl-2 in transgenic mice.
Fromm L; Overbeek PA
Dev Genet; 1997; 20(3):276-87. PubMed ID: 9216067
[TBL] [Abstract][Full Text] [Related]
15. Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect.
Osanai M; Ogawa K; Lee GH
Cancer Res; 1997 Jul; 57(14):2896-903. PubMed ID: 9230198
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways.
Li M; Hu J; Heermeier K; Hennighausen L; Furth PA
Cell Growth Differ; 1996 Jan; 7(1):13-20. PubMed ID: 8788029
[TBL] [Abstract][Full Text] [Related]
17. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis.
Marin MC; Hsu B; Meyn RE; Donehower LA; el-Naggar AK; McDonnell TJ
Oncogene; 1994 Nov; 9(11):3107-12. PubMed ID: 7936633
[TBL] [Abstract][Full Text] [Related]
18. Suppression of developmental retinal cell death but not of photoreceptor degeneration in Bax-deficient mice.
Mosinger Ogilvie J; Deckwerth TL; Knudson CM; Korsmeyer SJ
Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1713-20. PubMed ID: 9699561
[TBL] [Abstract][Full Text] [Related]
19. Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice.
Peirce SK; Chen WY
Oncogene; 2004 Feb; 23(6):1248-55. PubMed ID: 14647416
[TBL] [Abstract][Full Text] [Related]
20. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
